Replies to post #258436 on NorthWest Biotherapeutics Inc (NWBO)

[sukus]

Ex, how do you know this Ex? You seemed so sure. I am not sure if this is correct.

“In the trial they were maxed out at about 75/y.”

[AVII77]

Cognate has recently opened up 16 additional suites, for a total of 22 suites of manufacturing capacity to support products for both EU and US markets and we’re well on our way to being able to support commercial-scale production.

So, they had only 6 clean rooms at the time Linda said they had the "capacity for 5000 patients/yr".

[GoodGuyBill]

So NWBO right NWBO now has the capacity to handle 250 patients a year and LP is a lier and you have have all of the real facts.

https://www.sec.gov/Archives/edgar/data/1072379/000114420413020507/v338517_10k.htm

Quote:
Cognate’s manufacturing facility for clinical-grade cell products is located in Memphis, Tennessee, near the airport. Memphis is a worldwide air shipping hub for both Federal Express and UPS. Cognate's facility is approximately 35,000 square feet and contains substantial expansion space in addition to the portions currently built out and in use. The current manufacturing facilities are sufficient to produce DCVax for at least several thousand patients per year — an amount well in excess of what is needed for the late stage clinical trial under way. There is a large amount of expansion space, which is already planned for build- -out in stages to allow for scale -up of production capacity in a modular fashion as the need increases for commercialization. This would allow Cognate's current facility to increase to a total capacity of some 5,000 patients per year. In addition, the manufacturing arrangements with Fraunhofer in Germany and Kings College London in the United Kingdom provide further manufacturing capacity and flexibility. As a comparison, Dendreon commercially launched its Provenge dendritic cell vaccine for prostate cancer with initial manufacturing capacity for only 2,000 patients per year for a cancer that occurs in at least 100,000 new cases per year In the U.S. alone.